BTI
CLBT icon

Blue Trust Inc’s Cellebrite CLBT Stock Holding History

Blue Trust Inc’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3K Sell
776
-24,014
-97% -$317K ﹤0.01% 1833
2026
Q1 		$342K Buy
24,790
+1,325
+6% +$20K ﹤0.01% 607
2025
Q4 		$423K Buy
23,465
+344
+1% +$6.18K ﹤0.01% 543
2025
Q3 		$428K Buy
23,121
+898
+4% +$14.1K ﹤0.01% 538
2025
Q2 		$356K Buy
22,223
+1,497
+7% +$26.7K ﹤0.01% 571
2025
Q1 		$403K Sell
20,726
-500
-2% -$10.5K 0.01% 470
2024
Q4 		$468K Buy
+21,226
New +$409K 0.01% 396

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Blue Trust Inc's CLBT Position: Q2 2026 in Review

Blue Trust Inc reduced its Cellebrite (CLBT) stake by 97% in Q2 2026, selling an estimated $317K and leaving 776 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1833.

Blue Trust Inc first reported a position in CLBT in Q4 2024 and has held it in 7 quarters since. The position peaked at $468K in Q4 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Blue Trust Inc held 776 shares of Cellebrite worth $11.3K as of Q2 2026.
  • Blue Trust Inc sold 24,014 Cellebrite shares in Q2 2026, an estimated $317K.
  • Cellebrite made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1833 holding.
  • Blue Trust Inc first reported a position in Cellebrite in Q4 2024 and has held it in 7 quarters since.
  • Blue Trust Inc's Cellebrite position peaked at $468K in Q4 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.